WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS

This group comprises agents, which inhibit fibrinolytic activity.
Combinations with vitamin K, see B02B - Vitamin K and other hemostatics.

The DDDs are based on treatment of hemorrhage associated with fibrinolysis.


B02AA Amino acids
B02AB Proteinase inhibitors

Combinations with aprotinin used as local hemostatics are classified in B02BC30.

Last updated: 2024-01-26